SI
AGN

Sofinnova Investments’s Allergan plc AGN Stock Holding History

Sofinnova Investments’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-134,433
Closed -$22.6M – 79
2019
Q3 		$22.6M Buy
134,433
+50,000
+59% +$8.15M 2.05% 15
2019
Q2 		$14.1M Sell
84,433
-4,232
-5% -$586K 1.3% 17
2019
Q1 		$13M Buy
+88,665
New +$12.9M 1.25% 16
2018
Q4 		– Sell
-96,021
Closed -$18.3M – 75
2018
Q3 		$18.3M Sell
96,021
-15,529
-14% -$2.85M 1.63% 15
2018
Q2 		$18.6M Buy
111,550
+102,171
+1,089% +$16.4M 2.11% 11
2018
Q1 		$1.58M Buy
+9,379
New +$1.57M 0.27% 17

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Sofinnova Investments's AGN Position: Q4 2019 in Review

Sofinnova Investments sold out of Allergan plc (AGN) in Q4 2019, closing a stake of 134,433 shares — an estimated $22.6M sold.

Sofinnova Investments first reported a position in AGN in Q1 2018 and held it in 6 quarters. The position peaked at $22.6M in Q3 2019. 957 funds tracked by Wall St. Rank hold AGN as of Q4 2019.

  • Sofinnova Investments reported no remaining Allergan plc position as of Q4 2019 after selling out during the quarter.
  • Sofinnova Investments sold 134,433 Allergan plc shares in Q4 2019, an estimated $22.6M.
  • Sofinnova Investments first reported a position in Allergan plc in Q1 2018 and held it in 6 quarters.
  • Sofinnova Investments's Allergan plc position peaked at $22.6M in Q3 2019.
  • 957 funds tracked by Wall St. Rank held Allergan plc as of Q4 2019.

Based on Sofinnova Investments's 13F filing for Q4 2019, filed 14 Feb 2020.